Vimarsana
Biggest News Aggregation in the World

Page 9 - Mark Lebwohl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Lebwohl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Lebwohl Today - Breaking & Trending Today

Biosimilars vs Biologic Originators: Similar Safety, Efficacy for Psoriasis, Hidradenitis Suppurativa? - Vimarsana News

Biosimilars vs Biologic Originators: Similar Safety, Efficacy for Psoriasis, Hidradenitis Suppurativa?

Apr 8, 2021 Good results from two studies, but questions remain Researchers of two recent studies — from Denmark and the U.S. — sought to determine whether biosimilars are as effective as their biologic originators in the treatment of psoriasis and of hidradenitis suppurativa. JAMA Dermatology, researchers from Denmark concluded that the biosimilar for adalimumab may be as effective as adalimumab originator for the treatment of patients with psoriasis. Patients who switched to an adalimumab biosimilar had similar drug retention as adalimumab originator, but more dermatologic adverse event...

Biosimilars Match Up With Originals for Skin Disorders - Vimarsana News

Biosimilars Match Up With Originals for Skin Disorders

email article A mandated, nonmedical switch from adalimumab (Humira) to a biosimilar for psoriasis did not lead to a drop-off in drug retention, according to a Danish registry analysis. A year after switching to a biosimilar, 92.0% of patients remained on treatment versus 92.1% of patients treated with adalimumab originator. Rates of discontinuation for any reason or for adverse events (AEs) did not differ between the two patient groups, although treatment with a biosimilar was associated with more dermatologic AEs. The two groups also did not differ significantly with respect to change...

How A Dermatologist Treats Her Dark Spots from Sun Exposure - Vimarsana News

How A Dermatologist Treats Her Dark Spots from Sun Exposure

Courtesy of Flora Kim Dermatologists prescribe products to their patients all day long, but have you ever wondered which ones they personally use? Welcome to Derm Diaries, a series where dermatologists share their skin woes—and solutions—so you can steal secrets from their skincare routines. Flora Kim, MD, FAAD didn't have becoming a skincare expert in her original plan. The South Korea-born, New York-raised dermatologist actually started her career with a lucrative job as a financial analyst at Morgan Stanley’s Mergers & Acquisitions Group. On September 11, 2001, however, she witne...

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentation at the Innovations in Dermatology Conference - Vimarsana News

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentation at the Innovations in Dermatology Conference

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentation at the Innovations in Dermatology Conference Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that an abstract containing interim analysis data from Dermavant's PSOARING 3 long-term, open-label safety study for tapinarof for the treatment of psoriasis in adults will be presented in poster format during the upcoming Innovations in Dermatology Virtual Spring Conference 2021, held from March 16-20, 2021. The f...